LncRNA as a Diagnostic and Prognostic Biomarker in Bladder Cancer: A Systematic Review and Meta-Analysis

OncoTargets and Therapy - New Zealand
doi 10.2147/ott.s167853
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Clinical Value of lncRNA MALAT1 as a Prognostic Marker in Human Cancer: Systematic Review and Meta-Analysis

BMJ Open
Medicine
2015English

Prognostic and Diagnostic Significance of Galectins in Pancreatic Cancer: A Systematic Review and Meta-Analysis

Cancer Cell International
Cancer ResearchOncologyGenetics
2019English

P27Kip1 as a Prognostic Factor in Breast Cancer: A Systematic Review and Meta-Analysis

Journal of Cellular and Molecular Medicine
Molecular MedicineCell Biology
2009English

Circular RNA as a Biomarker for Cancer: A Systematic Meta‑analysis

Oncology Letters
Cancer ResearchOncology
2018English

Prognostic Value of microRNAs in Lung Cancer: A Systematic Review and Meta‑analysis

Molecular and Clinical Oncology
Cancer ResearchOncology
2018English

Plasma Mesothelin as a Novel Diagnostic and Prognostic Biomarker in Colorectal Cancer

Journal of Cancer
Oncology
2017English

Prognostic Value of Perineural Invasion in Gastric Cancer: A Systematic Review and Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Prognostic Value of MUC2 Expression in Colorectal Cancer: A Systematic Review and Meta-Analysis

Gastroenterology Research and Practice
HepatologyGastroenterology
2018English

Bladder Cancer-Associated Protein, a Potential Prognostic Biomarker in Human Bladder Cancer

Molecular and Cellular Proteomics
BiochemistryMedicineAnalytical ChemistryMolecular Biology
2009English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy